Note 9 - Operating Segment Information - Information Related to the Operations of the Company's Operating Segments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net sales	$ 138,842	$ 130,773
Segment EBITDA	9,631	6,903
Depreciation and amortization	3,252	3,388
Capital expenditures	675	2,114
Depreciation and amortization	3,252	3,388
Operating Segments [Member] | Branded Products [Member]
Net sales	87,068	81,851
Segment EBITDA	9,947	7,510
Depreciation and amortization	1,500	1,664
Capital expenditures	265	1,271
Depreciation and amortization	1,500	1,664
Operating Segments [Member] | Healthcare Apparel [Member]
Net sales	29,237	28,154
Segment EBITDA	2,635	1,572
Depreciation and amortization	937	974
Capital expenditures	173	462
Depreciation and amortization	937	974
Operating Segments [Member] | Contact Centers [Member]
Net sales	23,552	22,056
Segment EBITDA	2,946	2,793
Depreciation and amortization	723	668
Capital expenditures	160	381
Depreciation and amortization	723	668
Intersegment Eliminations [Member]
Net sales	(1,015)	(1,288)
Segment EBITDA	0	0
Depreciation and amortization	0	0
Capital expenditures	0	0
Depreciation and amortization	0	0
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]
Net sales	0	0
Segment EBITDA	(5,897)	(4,972)
Depreciation and amortization	92	82
Capital expenditures	77	0
Depreciation and amortization	$ 92	$ 82